ZA906583B - Method and composition for the treatment of cutaneous,ocular,and mucosal hypersensitivity,inflammatory,and hyperproliferative conditions using topical preparations of nifedipine - Google Patents

Method and composition for the treatment of cutaneous,ocular,and mucosal hypersensitivity,inflammatory,and hyperproliferative conditions using topical preparations of nifedipine

Info

Publication number
ZA906583B
ZA906583B ZA906583A ZA906583A ZA906583B ZA 906583 B ZA906583 B ZA 906583B ZA 906583 A ZA906583 A ZA 906583A ZA 906583 A ZA906583 A ZA 906583A ZA 906583 B ZA906583 B ZA 906583B
Authority
ZA
South Africa
Prior art keywords
nifedipine
cutaneous
ocular
inflammatory
treatment
Prior art date
Application number
ZA906583A
Inventor
Richard J Sharpe
J Sharpe Richard
Kenneth A Arndt
A Arndt Kenneth
Stephen J Galli
J Galli Stephen
Original Assignee
Beth Israel Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beth Israel Hospital filed Critical Beth Israel Hospital
Publication of ZA906583B publication Critical patent/ZA906583B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA906583A 1989-08-21 1990-07-20 Method and composition for the treatment of cutaneous,ocular,and mucosal hypersensitivity,inflammatory,and hyperproliferative conditions using topical preparations of nifedipine ZA906583B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39684689A 1989-08-21 1989-08-21

Publications (1)

Publication Number Publication Date
ZA906583B true ZA906583B (en) 1991-09-25

Family

ID=23568865

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA906583A ZA906583B (en) 1989-08-21 1990-07-20 Method and composition for the treatment of cutaneous,ocular,and mucosal hypersensitivity,inflammatory,and hyperproliferative conditions using topical preparations of nifedipine

Country Status (5)

Country Link
AU (1) AU6291990A (en)
IE (1) IE903013A1 (en)
PT (1) PT95061A (en)
WO (1) WO1991002497A1 (en)
ZA (1) ZA906583B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2758263A1 (en) * 1997-01-16 1998-07-17 Oreal USE OF AN ANTAGONIST OR AN AGONIST OF SEROTONIN RESPECTIVELY OF THE RECEPTOR 5HT2 AND 5HT1D IN A COSMETIC OR DERMATOLOGICAL COMPOSITION FOR SENSITIVE SKIN AND COMPOSITION OBTAINED
US6031005A (en) * 1998-08-03 2000-02-29 Easterling; W. Jerry Composition and method for treating Peyronie's disease and related connective tissue disorders

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5552162A (en) * 1993-02-09 1996-09-03 Arch Development Corporation Method for improvement of scar size and appearance
US5484788A (en) * 1993-03-26 1996-01-16 Beth Israel Hospital Association Buspirone as a systemic immunosuppressant
US5631017A (en) * 1993-03-26 1997-05-20 Beth Israel Deaconess Medical Center, Inc. Topical application of buspirone for treatment of pathological conditions associated with immune responses
AU2385795A (en) * 1994-04-12 1995-10-30 Alza Corporation Screening methods for integumental inflammation modulating agents
US5637314A (en) * 1995-06-07 1997-06-10 Beth Israel Deaconess Medical Center, Inc. Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis
US6225327B1 (en) 1996-04-18 2001-05-01 Alcon Laboratories, Inc. Compounds which inhibit human conjunctival mast cell degranulation for treating ocular allergic-type complications
WO1999000129A1 (en) 1997-06-30 1999-01-07 Dreyer Evan B Calcium blockers to treat proliferative vitreoretinopathy
FR2793681B1 (en) * 1999-05-18 2001-06-22 Oreal USE OF AT LEAST ONE INHIBITOR OF AT LEAST ONE CALCIUM CHANNEL IN THE TREATMENT OF WRINKLES
EP2377532A1 (en) * 2004-08-18 2011-10-19 Ace ApS Cosmetic and pharmaceutical compositions comprising ACE inhibitors and/or angiotensin II receptor antagonists for treating dermatological disorders
ITRM20060440A1 (en) * 2006-08-10 2008-02-11 Carmine Antropoli USE OF THE NIFEDIPINE FOR ANTI-WRINKLE TREATMENT
CA2968861C (en) * 2017-05-30 2022-10-11 University Of Saskatchewan Topical nifedipine formulations and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4637930A (en) * 1984-02-08 1987-01-20 Yamanouchi Pharmaceutical Co, Ltd. Transdermal formulation of nicardipine hydrochloride
DE3601196A1 (en) * 1986-01-17 1987-07-23 Merck Patent Gmbh 1,4-DIHYDROPYRIDINE

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2758263A1 (en) * 1997-01-16 1998-07-17 Oreal USE OF AN ANTAGONIST OR AN AGONIST OF SEROTONIN RESPECTIVELY OF THE RECEPTOR 5HT2 AND 5HT1D IN A COSMETIC OR DERMATOLOGICAL COMPOSITION FOR SENSITIVE SKIN AND COMPOSITION OBTAINED
WO1998031335A3 (en) * 1997-01-16 1999-09-10 Oreal Use of a serotonin antagonist and/or agonist respectively specific of the 5ht2 and 5ht1d receptor in a cosmetic or dermatological composition for sensitive skin and resulting composition
US6031005A (en) * 1998-08-03 2000-02-29 Easterling; W. Jerry Composition and method for treating Peyronie's disease and related connective tissue disorders

Also Published As

Publication number Publication date
AU6291990A (en) 1991-04-03
IE903013A1 (en) 1991-02-27
PT95061A (en) 1991-05-22
WO1991002497A1 (en) 1991-03-07

Similar Documents

Publication Publication Date Title
AU654119B2 (en) Isoxazolines, method of preparation thereof, and their use as plant-protection agents
AU8148987A (en) Method and compositions for reducing neurotoxic injury
AU7689791A (en) Drug-free method for treatment of alopecia
AU7078587A (en) Quinoline-3-carboxylic acid derivatives, their preparation and use
AU7180387A (en) Topical antimicrobial pharmaceutical compositions and methods
AU4770190A (en) Skin treatment method
AU5287090A (en) Method and composition for treatment of periodontal disease
AU639975B2 (en) Topical preparations for treating human nails
AU7132987A (en) Treatment of fungal infections
ZA906583B (en) Method and composition for the treatment of cutaneous,ocular,and mucosal hypersensitivity,inflammatory,and hyperproliferative conditions using topical preparations of nifedipine
EP0249736A3 (en) Ointment for the treatment of skin diseases
AU2169488A (en) Scalp treatment method
AU7044087A (en) Crop treatment processes
EP0468684A3 (en) Propenoic acid derivatives, process for their preparation and their use as fungicides
AU2597688A (en) 2,2-difluorocyclopropylethane derivatives, process for their preparation and their use as pesticides
AU1271592A (en) Malic acid derivatives and compositions for the treatment of psoriasis
FI92205C (en) Process for the Preparation of Therapeutically Useful N-Pyrrolo and Pyrido / 3,2,1, -jk / / 1,4 / Benzodiazepinyl-N'-arylurea
AU7875487A (en) Methods, compositions and solutions for treating alopecia
IE870577L (en) Topical amide preparation
EP0495485A3 (en) Phenoxyalkylcarboxylic acid derivatives, process of preparing the same and anti-allergic agents
IL66071A (en) Method and compositions for the topical treatment of glaucoma comprising aminoacid derivatives
IL95749A0 (en) Substituted anthranilic acid derivatives,their preparation and their use as anthelmintics
IL86970A0 (en) Ascorbic acid derivative,its preparation and its use as antioxidant
EP0373613A3 (en) Pyridine-3-percarboxylic acid monopersulfate
ZA906582B (en) Method and composition for the treatment of cutaneous,ocular,and mucosal hypersensitivity,inflammation,and hyperproliferative conditions using topical preparations of serotonin antagonists